BCR anticorps (AA 1042-1243)

N° du produit ABIN5013247

Cet anticorps anti-BCR est un anticorps Lapin Polyclonal détectant BCR dans WB, IHC, ICC et IP. Adapté pour Humain.

Aperçu rapide pour BCR anticorps (AA 1042-1243) (ABIN5013247)

Antigène: BCR (Breakpoint Cluster Region (BCR))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp BCR est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunoprecipitation (IP)

Détail du produit anti-BCR anticorps

Épitope: AA 1042-1243

Fonction: Polyclonal Antibody to Breakpoint Cluster Region (BCR)

Specificité: The antibody is a rabbit polyclonal antibody raised against BCR. It has been selected for its ability to recognize BCR in immunohistochemical staining and western blotting.

Réactivité croisée: Souris, Porc, Rat

Purification: Antigen-specific affinity chromatography followed by Protein A affinity chromatography

Immunogène: RPC328Hu01Recombinant Breakpoint Cluster Region (BCR)

Isotype: IgG

Information d'application

Indications d'application: Western blotting: 0.5-2 μg/mL,Immunohistochemistry: 5-20 μg/mL,Immunocytochemistry: 5-20 μg/mL,Optimal working dilutions must be determined by end user.

Commentaires:

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 500 μg/mL

Buffer: 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.

Agent conservateur: ProClin

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Détails sur BCR

Antigène: BCR (Breakpoint Cluster Region (BCR))

Autre désignation: Breakpoint Cluster Region

Sujet: ALL, BCR/FGFR1, BCR1, CML, FGFR1/BCR, PHL, Renal carcinoma antigen NY-REN-26

Pathways: Regulation of Leukocyte Mediated Immunity, Platelet-derived growth Factor Receptor Signaling